Rare Disease

Exploring the Implementation of Quality Care Programs for Patients with Myeloproliferative Neoplasms

Bruce Feinberg, DO; Kathy Oubre, Michael Reff, RPh, MBA; Jamile M. Shammo, MD; and Ruben Mesa, MD, discuss the incorporation of quality care programs for improved disease management and patient care for MPNs.

Exploring the Implementation of Quality Care Programs for Patients with Myeloproliferative Neoplasms peer exchange

Latest News

Neoplasms, cancerous disease, malignant tumour | Ирина Батюк - stock.adobe.com
NCCN Guidelines Update Adds Momelotinib Below Ruxolitinib for High-, Low-Risk Myelofibrosis

January 23rd 2024

Momelotinib was given category 2A and 2B status for patients with high- and low-risk myelofibrosis (MF) and MF with anemia. However, ruxolitinib retains a higher category of recommendation as a treatment for patients with MF.

Top 5 Most-Read Rare Disease Articles of 2023
Top 5 Most-Read Rare Disease Articles of 2023

December 29th 2023

sickle cell disease | Image credit: Dr_Microbe - stock.adobe.com
Interventions Needed to Increase DMT Uptake in Sickle Cell Disease

December 26th 2023

Polycythemia vera, a rare slow-growing blood cancer with an increase in the number of red blood cells | Dr_Microbe - stock.adobe.com
Age-Adjusted Index, Machine Learning Are Significant Factors for Predicting Thrombosis in Polycythemia Vera

December 18th 2023

Matthew Frigault, MD, MS, Harvard Medical School, Massachusetts General Hospital Cancer Center
Novel BCMA-Directed CAR Anito-Cel Is Highly Effective for Myeloma

December 12th 2023

More News

CH LogoCenter for Biosimilars Logo